Emergency Management of an - HPS Chaptershpschapters.org/northcarolina/fall2016/Christine Krieman...
Transcript of Emergency Management of an - HPS Chaptershpschapters.org/northcarolina/fall2016/Christine Krieman...
All Rights Reserved, Duke Medicine 2007
Emergency Management
of an 131I-MIBG Patient
in Medical ICU
Greg Egan and Christine Krieman
Duke University / Duke Health
OESO-Radiation Safety Division
All Rights Reserved, Duke Medicine 2007
• An acronym for “meta-iodo-benzylguanidine”
• Is a radioactive drug (which are also called
“radiopharmaceuticals”)
• Is a form of “systemic” radiation therapy, as opposed to
external beam therapy or brachytherapy
• Is used to treat tumors arising from the embryonic
neural crest
What is 131I-Metaiodobenzylguanidine (MIBG)?
All Rights Reserved, Duke Medicine 2007
“Neuroendocrine” Tumors That Can be
Treated With MIBG
• Carcinoid Tumors
• Pheochromocytoma
• Neuroblastoma (mainly children)
• Medullary Thyroid Carcinoma
131I-Metaiodobenzylguanidine (MIBG) therapy
All Rights Reserved, Duke Medicine 2007
Epinephrine (Adrenaline)
C C C
MIBG
Biochemical precursors of epinephrine are
preferentially concentrated by “neuroendocrine” tumors.
MIBG vs. Epinephrine
All Rights Reserved, Duke Medicine 2007
131I-Metaiodobenzylguanidine (MIBG) therapy
NC HPS, Fall 2016
A beta particle hits the DNA in the nucleus of a
replicating tumor cell,
causing the cell to die during mitosis.
-
DNA
All Rights Reserved, Duke Medicine 2007
NC HPS, Fall 2016
• Patient is injected with 504 mCi 131I-MIBG IV
• Exposure rate at 1m from patient immediately after infusion: 65 mR/hr
9/30/15
2:30 PM
504 mCi
administered
131I-MIBG therapy: Timeline
All Rights Reserved, Duke Medicine 2007
NC HPS, Fall 2016
• Code Blue is called for apparent respiratory arrest
• Hospital Code Blue team responds (23 people)
• Three Duke RSD HPs present (two are new to Duke)
• Patient is stabilized and required to be moved to Medical Intensive Care
Unit (MICU)
• Floor nurses cleaned up infusion room after patient is transferred to
MICU
9/30/15
3:00 PM
1st Code
Blue called
9/30/15
2:30 PM
504 mCi
administered
131I-MIBG therapy: Timeline
All Rights Reserved, Duke Medicine 2007
NC HPS, Fall 2016
• Code Blue Team – 23 individuals
• Estimated personnel exposures calculated from:
• Stay times ranged from 5 – 55 minutes
• Two distances from patient used for each responder’s dose
• Occupancy factor applied at each distance
• Exposures ranged from 4 – 131 mrem
9/30/15
3:00 PM
1st Code
Blue called
9/30/15
2:30 PM
504 mCi
administered
131I-MIBG therapy: Timeline
All Rights Reserved, Duke Medicine 2007
NC HPS, Fall 2016
• Patient transferred to MICU
• Corner room identified to house patient; adjacent room was evacuated
• RSD escorted patient and provided training to medical team:
• PPE required
• Time, Distance and Shielding, ALARA
• Issued dosimeters to key nursing staff
• Staff time in / time out log created
• Restrictions posted on patient’s door
• RSD contact information posted on patient’s door
9/30/15
3:00 PM
1st Code
Blue called
9/30/15
6:00 PM
Transferred
to MICU
9/30/15
2:30 PM
504 mCi
administered
131I-MIBG therapy: Timeline
All Rights Reserved, Duke Medicine 2007
NC HPS, Fall 2016
131I-MIBG Patient
Restroom
Sofa
Workstation
Workstation
Trash
Vacated
patient room
9/30/15
3:00 PM
1st Code
Blue called
9/30/15
6:00 PM
Transferred
to MICU
9/30/15
2:30 PM
504 mCi
administered
Patient room in MICU
131I-MIBG therapy: Timeline
All Rights Reserved, Duke Medicine 2007
• Family Visitation
• Attending Nuclear Medicine physician requested limited visits for
patient’s spouse and one adult family member
• RSD provided stay time for two locations in the patient’s room
(sofa and bedside)
• RSD present during all in-room visits with patient to ensure proper
PPE was worn, monitored time, and ALARA instructions were
followed
9/30/15
3:00 PM
1st Code
Blue called
9/30/15
6:00 PM
Transferred
to MICU
9/30/15
2:30 PM
504 mCi
administered
131I-MIBG therapy: Timeline
All Rights Reserved, Duke Medicine 2007
NC HPS, Fall 2016
131I-MIBG therapy: Timeline
• Second cardiopulmonary arrest; Code Blue called
• Patient was intubated and central venous access was obtained
• Impaired renal function developed; in-room continuous
hemodialysis begun
• Intensive nursing care was given throughout the evening
9/30/15
3:00 PM
1st Code
Blue called
9/30/15
6:00 PM
Transferred
to MICU
9/30/15
7:30 PM
2nd Code
Blue called
9/30/15
2:30 PM
504 mCi
administered
All Rights Reserved, Duke Medicine 2007
NC HPS, Fall 2016
131I-MIBG therapy: Timeline
• Patient was taken to Radiology for CT scan
• RSD HPs accompanied patient to Radiology and remained
present during scan
• CT indicated perforated bowel
• Patient’s family requested comfort measures only
9/30/15
3:00 PM
1st Code
Blue called
9/30/15
6:00 PM
Transferred
to MICU
9/30/15
7:30 PM
2nd Code
Blue called
10/1/15
4:00 PM
CT scan in
Radiology
9/30/15
2:30 PM
504 mCi
administered
All Rights Reserved, Duke Medicine 2007
NC HPS, Fall 2016
9/30/15
3:00 PM
1st Code
Blue called
9/30/15
6:00 PM
Transferred
to MICU
9/30/15
7:30 PM
2nd Code
Blue called
10/1/15
4:00 PM
CT scan in
Radiology
10/4/15
8:00 PM
Patient
dies
• Patient died on October 4, 2015 at 8:00 PM
• The funeral home retrieved the body the following morning
• Information for funeral home personnel about bodies
containing radioactive materials was reviewed with the staff
and provided to the driver
• No subsequent contact from the funeral home
9/30/15
2:30 PM
504 mCi
administered
131I-MIBG therapy: Timeline
All Rights Reserved, Duke Medicine 2007
Summary and Conclusions
• Life-threatening illness in a hospitalized MIBG patient is a rare
occurrence
• Creativity and flexibility are required in managing unexpected
events as they occur • Some aspects of patient care just don’t have “SOPs”!
• Radiation exposures to code team, nursing staff and family
members are manageable